Skip to main content Back to Top

GLP Practice Insights: GLP-1 Receptor Agonists and Neurodegenerative Disorders (CE)

August 22, 2026


ABOUT THIS PODCAST

This session discusses the potential sites of action and benefits for GLP-1 agonists (GLP-1a) in the pathology of two neurodegenerative disorders, Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). This session will also review the published and pending clinical literature of FDA approved GLP-1a use in AD and PD.


SPEAKERS

  • Nancy Lee, PharmD
    Clinical Pharmacy Specialist
    University of Iowa Health Care
  • Dana Carroll, PharmD, BCPS, BCGP, CDCES
    Clinical Professor
    Auburn University
  • Michelle Link Patterson, PharmD, BCACP, CDCES
    Clinical Pharmacy Specialist, Ambulatory Care
    Lankenau Medical Center

LISTEN ON


iTunes      Google            Spotify      TuneIn      iHeart Radio


The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

ASHP Podcasts